PROQR THERAPEUTICS NV
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs applyAbout PRQR
ProQR Therapeutics N.V. is a pre-clinical stage biopharmaceutical company based in the Netherlands. The Company is engaged in the discovery and development of ribonucleic Acid (RNA)-based therapeutics for the treatment of severe genetic disorders. It designs its therapeutic candidates to specifically target and repair the defective messenger RNA, or Messenger Ribonucleic Acid (mRNA), that is transcribed from a mutated gene in order to restore the expression and function of normal, or wild-type protein. Its product candidates include QR-010, an RNA-based oligonucleotide for the treatment of cystic fibrosis (CF), QR-110, an oligonucleotide and for the treatment of Leber’s congenital amaurosis (LCA).
Buy US stocks in Australia starting with PRQR. Open an account and start investing today!
$153.42M
-
0.00%
19.96K
$1.92
$1.87
$1.90
$3.29
$1.11
Ready to start your investing journey with Stake?
Open an accountPRQR FAQs
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake Wall St
- Deposit directly into your Stake wallet and you're ready to invest in PRQR
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PRQR
on Stake
Buy PRQR from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of PRQR from only US$10 with fractional shares
![Canstar award phone](/_next/image?url=%2Fimages%2Fstocks%2Fsidebar_phone_4x.png&w=3840&q=75)